E

ELEVAI Labs Inc
NASDAQ:ELAB

Watchlist Manager
ELEVAI Labs Inc
NASDAQ:ELAB
Watchlist
Price: 2.34 USD 2.63%
Market Cap: 1.7m USD
ELAB
/
Income Statement
/
Revenue

ELEVAI Labs Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ELEVAI Labs Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
E
ELEVAI Labs Inc
NASDAQ:ELAB
Revenue
$1.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Kenvue Inc
NYSE:KVUE
Revenue
$15.5B
CAGR 3-Years
1%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Safety Shot Inc
NASDAQ:SHOT
Revenue
$702k
CAGR 3-Years
-38%
CAGR 5-Years
134%
CAGR 10-Years
N/A
N
Nevis Brands Inc
CNSX:NEVI
Revenue
CA$1.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Horizon Kinetics Holding Corp
OTC:HKHC
Revenue
$4.1m
CAGR 3-Years
-49%
CAGR 5-Years
-35%
CAGR 10-Years
-15%

ELEVAI Labs Inc
Glance View

Market Cap
1.7m USD
Industry
Consumer products

ELEVAI Labs Inc is a US-based company operating in Personal Care Products industry. The company is headquartered in Newport Beach, California. The company went IPO on 2023-11-21. Elevai Labs, Inc. is a physician-dispensed skincare company. The firm conducts research and development to advance science-driven topical skincare that complements the medical aesthetics industry. The company produces and commercializes topical skincare products that contain its proprietary stem cell derived Elevai Exosomes designed to enhance the appearance of skin. Its Precision Regenerative Exosome Technology (PREx) biotechnology process yields exosome lots from human umbilical cord-derived mesenchymal stem cells (hUMSC) for its specialty physician-dispensed skincare products. The company has integrated the use of stem cell exosomes into its initial product line: Elevai Post Treatment E-Series. The E-Series comprises two post-skincare procedure care products that target the face and neck, and upper chest regions. Its products include Empower and Enfinity serums. Empower is its after-treatment topical product that supports the appearance of healthy skin and promotes an even toned complexion.

ELAB Intrinsic Value
6.69 USD
Undervaluation 65%
Intrinsic Value
Price
E
What is Intrinsic Value?

See Also

What is ELEVAI Labs Inc's Revenue?
Revenue
1.7m USD

Based on the financial report for Dec 31, 2023, ELEVAI Labs Inc's Revenue amounts to 1.7m USD.

What is ELEVAI Labs Inc's Revenue growth rate?
Revenue CAGR 1Y
122%

Over the last year, the Revenue growth was 122%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 251,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.